BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22013153)

  • 1. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population.
    Hadaegh F; Hatami M; Mohebi R; Hasheminia M; Bozorgmanesh M; Sheikholeslami F; Azizi F
    Eur J Prev Cardiol; 2012 Dec; 19(6):1227-33. PubMed ID: 22013153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does an electrocardiogram add predictive value to the rose angina questionnaire for future coronary heart disease? 10-year follow-up in a Middle East population.
    Khalili D; Hadaegh F; Fahimfar N; Shafiee G; Sheikholeslami F; Ghanbarian A; Azizi F
    J Epidemiol Community Health; 2012 Dec; 66(12):1104-9. PubMed ID: 22544919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic Minnesota code findings predicting short-term mortality in asymptomatic subjects. The Italian RIFLE Pooling Project (Risk Factors and Life Expectancy).
    Menotti A; Seccareccia F
    G Ital Cardiol; 1997 Jan; 27(1):40-9. PubMed ID: 9199942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic abnormalities improve classification of coronary heart disease risk in women: Tehran Lipid and Glucose Study.
    Hadaegh F; Mohebi R; Bozorgmanesh M; Saadat N; Sheikholeslami F; Azizi F
    Atherosclerosis; 2012 May; 222(1):110-5. PubMed ID: 22385984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience.
    Reunanen A; Aromaa A; Pyörälä K; Punsar S; Maatela J; Knekt P
    Acta Med Scand Suppl; 1983; 673():1-120. PubMed ID: 6578675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
    Daniels LB; Grady D; Mosca L; Collins P; Mitlak BH; Amewou-Atisso MG; Wenger NK; Barrett-Connor E;
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):164-70. PubMed ID: 23481531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative.
    Rautaharju PM; Kooperberg C; Larson JC; LaCroix A
    Circulation; 2006 Jan; 113(4):473-80. PubMed ID: 16449726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease.
    Ho KT; Miller TD; Hodge DO; Bailey KR; Gibbons RJ
    Mayo Clin Proc; 2002 Jun; 77(6):515-21. PubMed ID: 12059120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up.
    Crow RS; Hannan PJ; Folsom AR
    Circulation; 2003 Oct; 108(16):1985-9. PubMed ID: 14517173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting electrocardiogram and risk of coronary heart disease in middle-aged British men.
    Whincup PH; Wannamethee G; Macfarlane PW; Walker M; Shaper AG
    J Cardiovasc Risk; 1995 Dec; 2(6):533-43. PubMed ID: 8665372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
    Schindhelm RK; Dekker JM; Nijpels G; Bouter LM; Stehouwer CD; Heine RJ; Diamant M
    Atherosclerosis; 2007 Apr; 191(2):391-6. PubMed ID: 16682043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly upsloping ST-segment on exercise ECG: a marker of reduced coronary heart disease mortality risk.
    Hodnesdal C; Prestgaard E; Erikssen G; Gjesdal K; Kjeldsen SE; Liestol K; Skretteberg PT; Erikssen J; Bodegard J
    Eur J Prev Cardiol; 2013 Aug; 20(4):541-8. PubMed ID: 22492865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.
    Hadaegh F; Ehteshami-Afshar S; Hajebrahimi MA; Hajsheikholeslami F; Azizi F
    Int J Cardiol; 2015 Mar; 182():334-9. PubMed ID: 25585379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
    Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
    Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: the DAI study.
    DAI Study Group
    Diabet Med; 2004 Jul; 21(7):738-45. PubMed ID: 15209767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.